Matches in Wikidata for { <http://www.wikidata.org/entity/Q66406259> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- Q66406259 description "clinical trial" @default.
- Q66406259 description "ensayu clínicu" @default.
- Q66406259 description "klinisch onderzoek" @default.
- Q66406259 description "клінічне випробування" @default.
- Q66406259 name "Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus" @default.
- Q66406259 name "Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus" @default.
- Q66406259 type Item @default.
- Q66406259 label "Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus" @default.
- Q66406259 label "Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus" @default.
- Q66406259 prefLabel "Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus" @default.
- Q66406259 prefLabel "Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus" @default.
- Q66406259 P1050 Q66406259-322F4AF3-6096-4A63-A4A6-F720BAA7FB78 @default.
- Q66406259 P1132 Q66406259-83C2712B-24A5-4512-B9B2-47845576309B @default.
- Q66406259 P1476 Q66406259-7D1D0C10-5A44-4BF7-994F-A3E1862472E9 @default.
- Q66406259 P17 Q66406259-03590413-2E9B-4825-BEB3-493CED544646 @default.
- Q66406259 P17 Q66406259-072CA275-F4C4-4DD0-A20E-FDD4874FFFCA @default.
- Q66406259 P17 Q66406259-11F7C906-4B1E-43CE-8A2A-3FF9E288E231 @default.
- Q66406259 P17 Q66406259-12573E66-A42A-4D9A-B95A-134E8BA082EF @default.
- Q66406259 P17 Q66406259-171372E5-FA44-44FD-83B2-3035EE262549 @default.
- Q66406259 P17 Q66406259-329788E6-4751-410E-A801-DEA33EF2DC32 @default.
- Q66406259 P17 Q66406259-32A21FD1-8684-423C-9883-1CFDC43AF601 @default.
- Q66406259 P17 Q66406259-3B80A1C7-1DC1-456B-9EA8-2C266AD8603E @default.
- Q66406259 P17 Q66406259-40712F55-EAA2-4386-8ED1-B28BA6D28BC3 @default.
- Q66406259 P17 Q66406259-40CC88D8-B8D3-4113-9661-252B8C3715EB @default.
- Q66406259 P17 Q66406259-49210C76-476B-4459-96BA-662B224400EF @default.
- Q66406259 P17 Q66406259-4F51812D-EE0C-4E93-8E6E-89941B640D10 @default.
- Q66406259 P17 Q66406259-6CCE62B4-2F14-4A07-8E43-3934D8BE88EE @default.
- Q66406259 P17 Q66406259-7E81ED4F-83D2-46C6-8C50-E849E3AF7F9B @default.
- Q66406259 P17 Q66406259-87973030-D250-4389-BDA9-DB721E9B0C43 @default.
- Q66406259 P17 Q66406259-8EF1BFA5-31E1-4F98-AB17-B9B79B678B28 @default.
- Q66406259 P17 Q66406259-B81CB941-59ED-4B06-AFFC-0CAF10088849 @default.
- Q66406259 P17 Q66406259-BAD3ED10-EC33-42C6-901C-6A6552687FF9 @default.
- Q66406259 P17 Q66406259-DC7E1B8F-5B9F-4DF4-BF54-E4BE3E23DCC3 @default.
- Q66406259 P17 Q66406259-E9014C2F-7774-4A45-BA27-DA1847CD9130 @default.
- Q66406259 P17 Q66406259-F3CA6DA9-94BB-449B-9341-ADC497354F28 @default.
- Q66406259 P17 Q66406259-F5401D06-56BB-4D9D-B981-78683A5D403C @default.
- Q66406259 P1813 Q66406259-A2CFC97D-E53C-4E08-88F8-E1204F5E2CA8 @default.
- Q66406259 P2899 Q66406259-B958FC2A-948B-45B8-AA6D-91E19322E299 @default.
- Q66406259 P3098 Q66406259-759F19DD-45E9-4184-A02B-2125458FF408 @default.
- Q66406259 P31 Q66406259-1F3FBBFC-17FB-4E49-90EC-CA37E49B11D5 @default.
- Q66406259 P4135 Q66406259-A08F0521-C9AD-4EFA-95AE-461F3C9445A5 @default.
- Q66406259 P580 Q66406259-9B78DFA0-D8CC-45C0-AF49-FB1AAA725F73 @default.
- Q66406259 P582 Q66406259-E18FEAD3-2324-4CB2-9287-2CA57C5C0D17 @default.
- Q66406259 P6099 Q66406259-AC49BCC1-6D66-4215-B5ED-86D94643D6A7 @default.
- Q66406259 P8363 Q66406259-984155DD-57EF-49E0-931F-D892BE653E45 @default.
- Q66406259 P1050 Q12206 @default.
- Q66406259 P1132 "+463" @default.
- Q66406259 P1476 "6-Month, Multicenter, Randomized, Open-label, 2-Arm, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected Once Daily in Children and Adolescents Age 6 - 17 Years With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period" @default.
- Q66406259 P17 Q142 @default.
- Q66406259 P17 Q145 @default.
- Q66406259 P17 Q155 @default.
- Q66406259 P17 Q16 @default.
- Q66406259 P17 Q17 @default.
- Q66406259 P17 Q183 @default.
- Q66406259 P17 Q211 @default.
- Q66406259 P17 Q218 @default.
- Q66406259 P17 Q219 @default.
- Q66406259 P17 Q221 @default.
- Q66406259 P17 Q28 @default.
- Q66406259 P17 Q29 @default.
- Q66406259 P17 Q298 @default.
- Q66406259 P17 Q30 @default.
- Q66406259 P17 Q34 @default.
- Q66406259 P17 Q35 @default.
- Q66406259 P17 Q36 @default.
- Q66406259 P17 Q38 @default.
- Q66406259 P17 Q403 @default.
- Q66406259 P17 Q414 @default.
- Q66406259 P17 Q801 @default.
- Q66406259 P17 Q96 @default.
- Q66406259 P1813 "EDITION JUNIOR" @default.
- Q66406259 P2899 "+6" @default.
- Q66406259 P3098 "NCT02735044" @default.
- Q66406259 P31 Q30612 @default.
- Q66406259 P4135 "+17" @default.
- Q66406259 P580 "2016-04-14T00:00:00Z" @default.
- Q66406259 P582 "2018-05-31T00:00:00Z" @default.
- Q66406259 P6099 Q42824827 @default.
- Q66406259 P8363 Q78089383 @default.